Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1)
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (1) , 6713-6723
Abstract
Long non-coding RNA (lncRNA) FGD5 antisense RNA 1 (FGD5-AS1) was reported to exert critical roles in multiple cancers. The current work aimed to determine the role of FGD5-AS1 in cisplatin (DDP) resistance of hepatocellular carcinoma (HCC). The levels of FGD5-AS1, miR-153-3p, and twinfilin actin binding protein 1 (TWF1) were analyzed using RT-qPCR. CCK-8, colony formation, Transwell, and TUNEL assays were used to examine the IC50 value of DDP, cell viability, invasion, and apoptosis. The interaction between miR-153-3p and TWF1 or FGD5-AS1 was determined by luciferase reporter and RIP assays. In our study, we found that FGD5-AS1 level was elevated in DDP-resistant HCC tissues and cell lines. FGD5-AS1 silencing improved the sensitivity of HCC cells to DDP. Moreover, FGD5-AS1 directly bound to miR-153-3p and FGD5-AS1 addition neutralized the inhibitory impacts of miR-153-3p supplementation on DDP resistance in the HCC cells. In addition, knockdown of TWF1 inhibited DDP resistance of HCC cells, which was reversed by miR-153-3p deletion. Lastly, FGD5-AS1 interference decreased TWF1 expression level, which was rescued by miR-153-3p inhibition. Our study exhibited that FGD5-AS1 promoted DDP resistance through modulating the miR-153-3p/TWF1 axis in HCC cells. This could be an effective treatment strategy for HCC patients.Keywords
Funding Information
- Six first Project (LGY2019022)
This publication has 35 references indexed in Scilit:
- circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axisBiochemical and Biophysical Research Communications, 2018
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Combinatorial genetic analysis of a network of actin disassembly‐promoting factorsCytoskeleton, 2015
- Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancerOncotarget, 2014
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular CarcinomaGastroenterology, 2013
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11Nature Communications, 2013
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA: A Cancer Journal for Clinicians, 2012
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- MicroRNAsCell, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001